Insomnia: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• TNF 0
• GLP-1 0
• BDNF 0
• AKT 0
• APOE 0
• CDK4/6 0
• CGRP 0
• COX-2 0
• G6PD 0
• GIP 0
• HSP90 0
• HTT 0
• IL-4 0
• IL-6 0
• JAK 0
• MAPT 0
• mTOR 0
• PARP 0
• PCSK9 0
• PI3K 0
• TLR4 0
• TTR 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 1,965 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

  NCT06498128· Idorsia Pharmaceuticals Ltd.· Updated 29 Oct 2026

  “The study, in its current operational format, has been terminated. However, data collection will continue through the National Pregnancy Registry for Psychiatric Medications (NPRPM), which is conducted by Massachusetts General Hospital (NCT01246765)”Registry text, quoted unchanged. Source

• Terminated

  MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

  NCT06274034· Mayo Clinic· Updated 15 Sept 2026

  “Funds expired”Registry text, quoted unchanged. Source

• Withdrawn

  Auditory Stimulation for Insomnia and Depression

  NCT07553364· Wake Forest University Health Sciences· Updated 27 Aug 2026

  “unable to obtain equipment needed for study”Registry text, quoted unchanged. Source

• Terminated

  Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

  NCT06162663· Medical University of South Carolina· Updated 12 Aug 2026

  “Terminated early due to insufficient accrual to meet prespecified statistical analysis requirements.”Registry text, quoted unchanged. Source

• Terminated

  Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

  NCT06843187· Unity Health Toronto· Updated 30 Jul 2026

  “Funding withdrawn by sponsor.”Registry text, quoted unchanged. Source

• Terminated

  The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

  NCT03436745· National Cancer Institute (NCI)· Updated 26 Jun 2026

  “Slow/insufficient accrual”Registry text, quoted unchanged. Source

• Withdrawn

  CBT-I in Adolescents With ADHD

  NCT07209969· The University of Hong Kong· Updated 22 Jun 2026

  “This entry was created by mistake.”Registry text, quoted unchanged. Source

• Withdrawn

  Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep

  NCT06840444· University of Kansas Medical Center· Updated 14 Apr 2026

  “No longer pursuing a trial for this project.”Registry text, quoted unchanged. Source

• Terminated

  Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans

  NCT05724498· VA Office of Research and Development· Updated 20 Mar 2026

  “Loss of investigator staff”Registry text, quoted unchanged. Source

• Suspended

  Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia

  NCT06910423· College of Professional and Continuing Education Limited· Updated 19 Mar 2026

  “Funding not available”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Melatonin versus quetiapine in adolescents (MEL-QUE-A)

  2024-519597-39-00· Region Hovedstaden· Source

• Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness

  NCT07760779· University of Pittsburgh· Source

• Treating Insomnia in Mild Cognitive Impairment

  NCT06687161· Beth Israel Deaconess Medical Center· Source

• Health enSuite Insomnia: an App-based Treatment for Adult Chronic Insomnia

  NCT04962087· IWK Health Centre· Source

• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Janssen Research & Development, LLC· Source

• Targeting Sleep and Slow-Wave Activity to Enhance Cognition in MCI

  NCT07911826· New York State Psychiatric Institute· Source

• Perinatal Research on Improving Sleep and Mental Health

  NCT05596318· University of California, San Francisco· Source

• Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery

  NCT07903051· Beijing Tiantan Hospital· Source

• Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation

  NCT07903038· Beijing Tiantan Hospital· Source

• Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

  NCT07280416· Centre Hospitalier Emile Roux· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Mendelian Randomization Analysis 41
• Gene Expression Profiling 9
• Exome Sequencing 1
• Proteomics 8
• Metabolomics 7
• Mass Spectrometry 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 66
• Machine Learning 34
• Deep Learning 3
• Cohort Studies 86
• Genome-Wide Association Study 37

See which targets of this disease your abstract mentions, and go to the people working on them.